Global Oncolytic Virus Therapy Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Oncolytic Virus Therapy market size will reach Million USD in 2025 and is projected to reach Million USD by 2032, with a CAGR of % (2025-2032). Notably, the China Oncolytic Virus Therapy market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Oncolytic virus therapy, also known as virotherapy, is a type of cancer treatment that utilizes genetically engineered or naturally occurring viruses to selectively target and destroy cancer cells. The viruses used in oncolytic virus therapy are designed to replicate within cancer cells, causing their death while leaving healthy cells unharmed. This therapy takes advantage of the natural ability of certain viruses to infect and replicate within cells. Oncolytic viruses can be modified to enhance their tumor targeting, safety, and anticancer effects. When administered to patients, these viruses selectively infect and replicate within cancer cells, leading to tumor cell lysis and the release of tumor-associated antigens. This process stimulates an immune response, promoting the recognition and destruction of both infected cancer cells and non-infected cancer cells. Oncolytic virus therapy has shown promise in preclinical and clinical trials for various types of cancer and may be used as a standalone treatment or in combination with other cancer therapies, such as chemotherapy, radiation, or immunotherapy. The field of oncolytic virus therapy continues to evolve, with ongoing research and clinical trials aiming to optimize the therapeutic potential and broaden the utility of this innovative treatment approach.
The major global suppliers of Oncolytic Virus Therapy include Amgen, Oncolytics Biotech, Viralytics, Oncolys BioPharma, Transgene SA, Targovax, PsiOxus Therapeutics, SillaJenBiotherapeutics, Genelux Corporation, Sorrento Therapeutics, Lokon Pharma, Cold Genesys, TILT Biotherapeutics, Vyriad, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Oncolytic Virus Therapy. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Oncolytic Virus Therapy market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Oncolytic Virus Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Oncolytic Virus Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Oncolytic Virus Therapy Include:
Amgen
Oncolytics Biotech
Viralytics
Oncolys BioPharma
Transgene SA
Targovax
PsiOxus Therapeutics
SillaJenBiotherapeutics
Genelux Corporation
Sorrento Therapeutics
Lokon Pharma
Cold Genesys
TILT Biotherapeutics
Vyriad
Oncolytic Virus Therapy Product Segment Include:
HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses
Oncolytic Virus Therapy Product Application Include:
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Oncolytic Virus Therapy Industry PESTEL Analysis
Chapter 3: Global Oncolytic Virus Therapy Industry Porter's Five Forces Analysis
Chapter 4: Global Oncolytic Virus Therapy Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Oncolytic Virus Therapy Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Oncolytic Virus Therapy Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Oncolytic Virus Therapy Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Oncolytic Virus Therapy market size will reach Million USD in 2025 and is projected to reach Million USD by 2032, with a CAGR of % (2025-2032). Notably, the China Oncolytic Virus Therapy market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Oncolytic virus therapy, also known as virotherapy, is a type of cancer treatment that utilizes genetically engineered or naturally occurring viruses to selectively target and destroy cancer cells. The viruses used in oncolytic virus therapy are designed to replicate within cancer cells, causing their death while leaving healthy cells unharmed. This therapy takes advantage of the natural ability of certain viruses to infect and replicate within cells. Oncolytic viruses can be modified to enhance their tumor targeting, safety, and anticancer effects. When administered to patients, these viruses selectively infect and replicate within cancer cells, leading to tumor cell lysis and the release of tumor-associated antigens. This process stimulates an immune response, promoting the recognition and destruction of both infected cancer cells and non-infected cancer cells. Oncolytic virus therapy has shown promise in preclinical and clinical trials for various types of cancer and may be used as a standalone treatment or in combination with other cancer therapies, such as chemotherapy, radiation, or immunotherapy. The field of oncolytic virus therapy continues to evolve, with ongoing research and clinical trials aiming to optimize the therapeutic potential and broaden the utility of this innovative treatment approach.
The major global suppliers of Oncolytic Virus Therapy include Amgen, Oncolytics Biotech, Viralytics, Oncolys BioPharma, Transgene SA, Targovax, PsiOxus Therapeutics, SillaJenBiotherapeutics, Genelux Corporation, Sorrento Therapeutics, Lokon Pharma, Cold Genesys, TILT Biotherapeutics, Vyriad, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Oncolytic Virus Therapy. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Oncolytic Virus Therapy market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Oncolytic Virus Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Oncolytic Virus Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Oncolytic Virus Therapy Include:
Amgen
Oncolytics Biotech
Viralytics
Oncolys BioPharma
Transgene SA
Targovax
PsiOxus Therapeutics
SillaJenBiotherapeutics
Genelux Corporation
Sorrento Therapeutics
Lokon Pharma
Cold Genesys
TILT Biotherapeutics
Vyriad
Oncolytic Virus Therapy Product Segment Include:
HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses
Oncolytic Virus Therapy Product Application Include:
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Oncolytic Virus Therapy Industry PESTEL Analysis
Chapter 3: Global Oncolytic Virus Therapy Industry Porter's Five Forces Analysis
Chapter 4: Global Oncolytic Virus Therapy Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Oncolytic Virus Therapy Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Oncolytic Virus Therapy Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Oncolytic Virus Therapy Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Oncolytic Virus Therapy Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Oncolytic Virus Therapy Product by Type
- 1.2.1 HSV-based Oncolytic Viruses
- 1.2.2 Adenoviruses-based Oncolytic Viruses
- 1.2.3 Vaccinia Virus-based Oncolytic Viruses
- 1.2.4 Vesicular Stomatitis Virus-based Oncolytic Viruses
- 1.2.5 Newcastle Disease Virus-based Oncolytic Viruses
- 1.3 Oncolytic Virus Therapy Product by Application
- 1.3.1 Melanoma
- 1.3.2 Prostate Cancer
- 1.3.3 Breast Cancer
- 1.3.4 Ovarian Cancer
- 1.3.5 Others
- 1.4 Global Oncolytic Virus Therapy Market Size Analysis (2020-2032)
- 1.5 Oncolytic Virus Therapy Market Development Status and Trends
- 1.5.1 Oncolytic Virus Therapy Industry Development Status Analysis
- 1.5.2 Oncolytic Virus Therapy Industry Development Trends Analysis
- 2 Oncolytic Virus Therapy Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Oncolytic Virus Therapy Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Oncolytic Virus Therapy Market Analysis by Country
- 4.1 Global Oncolytic Virus Therapy Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Oncolytic Virus Therapy Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Oncolytic Virus Therapy Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Oncolytic Virus Therapy Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Oncolytic Virus Therapy Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Oncolytic Virus Therapy Market Revenue and Growth Rate (2020-2032)
- 4.5 China Oncolytic Virus Therapy Market Revenue and Growth Rate (2020-2032)
- 4.6 France Oncolytic Virus Therapy Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Oncolytic Virus Therapy Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Oncolytic Virus Therapy Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Oncolytic Virus Therapy Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Oncolytic Virus Therapy Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Oncolytic Virus Therapy Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Oncolytic Virus Therapy Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Oncolytic Virus Therapy Market Revenue and Growth Rate (2020-2032)
- 4.14 India Oncolytic Virus Therapy Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Oncolytic Virus Therapy Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Oncolytic Virus Therapy Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Oncolytic Virus Therapy Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Oncolytic Virus Therapy Market Revenue by Key Suppliers (2021-2025)
- 5.2 Oncolytic Virus Therapy Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Oncolytic Virus Therapy Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Oncolytic Virus Therapy Market Analysis by Type
- 6.1 Global Oncolytic Virus Therapy Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Oncolytic Virus Therapy Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Amgen
- 7.1.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Amgen Oncolytic Virus Therapy Product Portfolio
- 7.1.3 Amgen Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Oncolytics Biotech
- 7.2.1 Oncolytics Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Oncolytics Biotech Oncolytic Virus Therapy Product Portfolio
- 7.2.3 Oncolytics Biotech Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Viralytics
- 7.3.1 Viralytics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Viralytics Oncolytic Virus Therapy Product Portfolio
- 7.3.3 Viralytics Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Oncolys BioPharma
- 7.4.1 Oncolys BioPharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Oncolys BioPharma Oncolytic Virus Therapy Product Portfolio
- 7.4.3 Oncolys BioPharma Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Transgene SA
- 7.5.1 Transgene SA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Transgene SA Oncolytic Virus Therapy Product Portfolio
- 7.5.3 Transgene SA Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Targovax
- 7.6.1 Targovax Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Targovax Oncolytic Virus Therapy Product Portfolio
- 7.6.3 Targovax Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 PsiOxus Therapeutics
- 7.7.1 PsiOxus Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 PsiOxus Therapeutics Oncolytic Virus Therapy Product Portfolio
- 7.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 SillaJenBiotherapeutics
- 7.8.1 SillaJenBiotherapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 SillaJenBiotherapeutics Oncolytic Virus Therapy Product Portfolio
- 7.8.3 SillaJenBiotherapeutics Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Genelux Corporation
- 7.9.1 Genelux Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Genelux Corporation Oncolytic Virus Therapy Product Portfolio
- 7.9.3 Genelux Corporation Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Sorrento Therapeutics
- 7.10.1 Sorrento Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Sorrento Therapeutics Oncolytic Virus Therapy Product Portfolio
- 7.10.3 Sorrento Therapeutics Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Lokon Pharma
- 7.11.1 Lokon Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Lokon Pharma Oncolytic Virus Therapy Product Portfolio
- 7.11.3 Lokon Pharma Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Cold Genesys
- 7.12.1 Cold Genesys Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Cold Genesys Oncolytic Virus Therapy Product Portfolio
- 7.12.3 Cold Genesys Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 TILT Biotherapeutics
- 7.13.1 TILT Biotherapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
